Regenerative medicines revenue in Latin America 2022-2027
By 2027, the regenerative medicines market in Latin America is expected to reach up to 6.5 billion U.S. dollars, up from the 2022 market value estimated at 2.15 billion U.S. dollars. A compound annual growth rate (CAGR) of 24.8 percent is expected for the period.